167 related articles for article (PubMed ID: 35320626)
1. Isolation of Tobacco Mosaic Virus-Binding Peptides for Biotechnology Applications.
Chan SK; Steinmetz NF
Chembiochem; 2022 Jun; 23(11):e202200040. PubMed ID: 35320626
[TBL] [Abstract][Full Text] [Related]
2. Propagation and Isolation of Tobacco Mosaic Virus That Surface Displays Metal Binding and Reducing Peptides for Generation of Gold Nanoparticles.
Love AJ; Taliansky ME
Methods Mol Biol; 2018; 1776():363-381. PubMed ID: 29869254
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
4. Tobacco Mosaic Virus as a Versatile Platform for Molecular Assembly and Device Fabrication.
Chu S; Brown AD; Culver JN; Ghodssi R
Biotechnol J; 2018 Dec; 13(12):e1800147. PubMed ID: 30288951
[TBL] [Abstract][Full Text] [Related]
5. Precise Assembly of Genetically Functionalized Magnetosomes and Tobacco Mosaic Virus Particles Generates a Magnetic Biocomposite.
Mickoleit F; Altintoprak K; Wenz NL; Richter R; Wege C; Schüler D
ACS Appl Mater Interfaces; 2018 Nov; 10(44):37898-37910. PubMed ID: 30360046
[TBL] [Abstract][Full Text] [Related]
6. Morphology and stability changes of recombinant TMV particles caused by a cysteine residue in the foreign peptide fused to the coat protein.
Li Q; Jiang L; Li M; Li P; Zhang Q; Song R; Xu Z
J Virol Methods; 2007 Mar; 140(1-2):212-7. PubMed ID: 17140672
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab-binding peptide display by Tobacco mosaic virus.
Frolova OY; Petrunia IV; Komarova TV; Kosorukov VS; Sheval EV; Gleba YY; Dorokhov YL
Virology; 2010 Nov; 407(1):7-13. PubMed ID: 20801474
[TBL] [Abstract][Full Text] [Related]
8. Historical overview of research on the tobacco mosaic virus genome: genome organization, infectivity and gene manipulation.
Okada Y
Philos Trans R Soc Lond B Biol Sci; 1999 Mar; 354(1383):569-82. PubMed ID: 10212936
[TBL] [Abstract][Full Text] [Related]
9. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of Tobacco Mosaic Virus-Like Nanorods for Peptide Display.
Larkin EJ; Brown AD; Culver JN
Methods Mol Biol; 2018; 1776():51-60. PubMed ID: 29869234
[TBL] [Abstract][Full Text] [Related]
11. The symptom difference induced by tobacco mosaic virus and tomato mosaic virus in tobacco plants containing the N gene is determined by movement protein gene.
Yu C; Hu D; Dong J; Cui X; Wu J; Yu J; Zhou X
Sci China C Life Sci; 2004 Dec; 47(6):503-9. PubMed ID: 15620106
[TBL] [Abstract][Full Text] [Related]
12. Tobacco mosaic virus (TMV) and potato virus X (PVX) coat proteins confer heterologous interference to PVX and TMV infection, respectively.
Bazzini AA; Asurmendi S; Hopp HE; Beachy RN
J Gen Virol; 2006 Apr; 87(Pt 4):1005-1012. PubMed ID: 16528051
[TBL] [Abstract][Full Text] [Related]
13. Assessing the spread of engineered TMV.
Campbell RN
Science; 1999 Oct; 286(5441):903. PubMed ID: 10577241
[No Abstract] [Full Text] [Related]
14. The physics of tobacco mosaic virus and virus-based devices in biotechnology.
Alonso JM; Górzny MŁ; Bittner AM
Trends Biotechnol; 2013 Sep; 31(9):530-8. PubMed ID: 23849673
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
McCormick AA; Palmer KE
Expert Rev Vaccines; 2008 Feb; 7(1):33-41. PubMed ID: 18251692
[TBL] [Abstract][Full Text] [Related]
16. In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system.
Fujiyama K; Saejung W; Yanagihara I; Nakado J; Misaki R; Honda T; Watanabe Y; Seki T
J Biosci Bioeng; 2006 May; 101(5):398-402. PubMed ID: 16781468
[TBL] [Abstract][Full Text] [Related]
17. Effects of the tom1 mutation of Arabidopsis thaliana on the multiplication of tobacco mosaic virus RNA in protoplasts.
Ishikawa M; Naito S; Ohno T
J Virol; 1993 Sep; 67(9):5328-38. PubMed ID: 8350399
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.
Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG
Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564
[TBL] [Abstract][Full Text] [Related]
19. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.
Pérez-Filgueira DM; Brayfield BP; Phiri S; Borca MV; Wood C; Morris TJ
J Virol Methods; 2004 Nov; 121(2):201-8. PubMed ID: 15381357
[TBL] [Abstract][Full Text] [Related]
20. Expression of tobacco mosaic virus RNA in transgenic plants.
Yamaya J; Yoshioka M; Meshi T; Okada Y; Ohno T
Mol Gen Genet; 1988 Mar; 211(3):520-5. PubMed ID: 2835637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
